SAGE to be Acquired by Supernus Pharmaceuticals in $795 Million Deal

• click to rate

  Posted by Two Blokes Jun 17 - Filed in Stock - 5 views
  
  SUPN inks deal to acquire Sage Therapeutics for up to $795 million, securing rights to depression drug Zurzuvae.